Developing models to understand infectious diseases.
Official title: Pre-Clinical Models of Infectious Diseases
Funded at University of Cincinnati · NIH-11197668 · Data updated 2026-11-12
This study is working on building models that mimic infectious diseases to help researchers find better ways to treat them, which could lead to new and improved treatment options for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Cincinnati NIH-funded |
| Lab location | 1 site (Cincinnati, United States) |
| Project start | July 15, 2024 |
| Project end | July 14, 2031 |
| Funding year | 2024 |
| Award (this year) | $2,500 |
| NIH project number | 75N93024D00033-0-759302400001-1 |
| Project ID | NIH-11197668 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals at risk of infectious diseases or those who may benefit from new medical countermeasures.
✕Less likely to help
Patients with non-infectious diseases or those who are not at risk for infectious diseases may not receive any benefit from this research.
What this research studies
This research focuses on creating pre-clinical models that simulate infectious diseases to better understand their mechanisms and potential treatments. By using these models, researchers aim to evaluate the effectiveness of medical countermeasures and develop new strategies for combating infectious diseases. Patients may benefit from advancements in treatment options that arise from the insights gained through these models.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments and preventive measures for infectious diseases.
How similar studies have gone: Previous research has shown success in using pre-clinical models to develop effective treatments for infectious diseases, indicating that this approach is both tested and promising.
Where this research is happening
-
University of Cincinnati
Cincinnati, United States Active
Related research
Other NIH-funded projects on the same topics.
-
Immune and nerve signals behind acupuncture relief for sickle cell pain
This NIH grant explores how acupuncture helps reduce pain and opioid use for people with sickle cell disease.
-
MnSOD modification drives a stem-cell like switch in some ER-positive breast cancers
A small study in ER-positive breast cancer looks at how a specific mitochondrial change (MnSOD-K68 acetylation) may push cancer cells toward a more stem-like, therapy-resistant state.
-
Lineage changes in cancer cells drive resistance to radiation and hormone therapy
A cancer-focused study looks at how a mitochondrial enzyme modification may cause tumor cells to resist radiation and hormone therapy in prostate cancer.
-
Repurposed Antiretroviral Therapies to Eliminate Cervical Cancer
A pilot study tests a self-administered vaginal capsule with protease inhibitors to safely treat cervical precancer (CIN 2/3) in women, using a non-invasive approach.
-
Recombinant factor VIIa given very early for bleeding stroke
This trial gives a clotting medicine called rFVIIa very soon after a spontaneous brain bleed to adults to try to improve recovery.
-
Early Factor VIIa treatment for bleeding stroke
This project tests whether giving a clotting medicine called recombinant Factor VIIa very soon after a spontaneous brain bleed helps adults recover better than standard care alone.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.